DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Bermack JE, Haddjeri N, Debonnel G.
Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus.
J Pharmacol Exp Ther 2004;
310 (02) 578-583
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.